Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiia Lepp

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Vaccines|June 27, 2025
Deficits in Long-Term Vaccine Immunity Among Childhood Cancer Survivors Despite Revaccination ProgramsAlexander Zadruzny, Eva Tiselius, Tiia Lepp, et al.
JAMA Oncology|December 18, 2025
Quadrivalent Human Papillomavirus Vaccine and High-Grade Vulvovaginal LesionsYunyang Deng, Shiqiang Wu, Lina Schollin Ask, et al.
BMJ (Clinical Research Ed.)|February 25, 2026
Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based studyShiqiang Wu, Yunyang Deng, Tiia Lepp, et al.
The Lancet. Infectious Diseases|December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysisJulia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
Microorganisms|April 30, 2021
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) ProjectMaria Deloria Knoll, Julia C Bennett, Maria Garcia Quesada, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Vaccines|June 27, 2025
Deficits in Long-Term Vaccine Immunity Among Childhood Cancer Survivors Despite Revaccination ProgramsAlexander Zadruzny, Eva Tiselius, Tiia Lepp, et al.
JAMA Oncology|December 18, 2025
Quadrivalent Human Papillomavirus Vaccine and High-Grade Vulvovaginal LesionsYunyang Deng, Shiqiang Wu, Lina Schollin Ask, et al.
BMJ (Clinical Research Ed.)|February 25, 2026
Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based studyShiqiang Wu, Yunyang Deng, Tiia Lepp, et al.
The Lancet. Infectious Diseases|December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysisJulia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
Microorganisms|April 30, 2021
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) ProjectMaria Deloria Knoll, Julia C Bennett, Maria Garcia Quesada, et al.
Pageof 2